NeuroOne Medical Technologies Corporation

NMTC
NASDAQ
Last Updated: 12/5/2022 9:00:04 PM
Price
1.63
Changes
0.12
% Change
7.95
Volume
177848
52 Week
High
3.18
52 Week
Low
0.51
About NeuroOne Medical Technologies Corporation
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.
NeuroOne Medical Technologies Corporation Company Details
CEO:   Mr. David A. Rosa
Country:   US
Industry:   Medical Devices
Website:   https://n1mtc.com
Exchange:   NASDAQ Capital Market
IPO\Launch Date:   2021-05-26
NeuroOne Medical Technologies Corporation Company Executive Details
  Mr. Hijaz Haris
  Vice President of Marketing
  Mr. Mark Christianson
  Co-Founder, Bus. Devel. Director & Medical Sales Liaison
  Mr. Steven Mertens
  Chief Technology Officer
  Mr. Ronald W. McClurg
  Chief Financial Officer
  Mr. David A. Rosa M.D.
  Pres, Chief Executive Officer & Director

NeuroOne Medical Technologies Corporation Latest News

Best Penny Stocks To Buy Now? 5 Biotech Stocks To Watch This Week


Biotech penny stocks to watch this week. Are they a buy now?


Published on: 2022-11-21 12:59:36

Impact on Symbol / Company: NMTC

View News

NeuroOne Medical Technologies Corporation (NMTC) CEO Dave Rosa on Q3 2022 Results - Earnings Call Transcript


NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q3 2022 Earnings Conference Call August 11, 2022 5:30 PM ET Company Participants Dave Rosa - President and Chief Executive Officer Ron McClurg - Chief Financial Officer Conference Call Participants Alexander Nowak - Craig-Hallum Capital Group Ben Haynor - Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by. And welcome to the NeuroOne Medical Technologies Corporation Third Quarter of Fiscal Year 2022 Financial Results Conference Call.


Published on: 2022-08-14 06:12:52

Impact on Symbol / Company: NMTC

View News

NeuroOne® to Present Its Breakthrough Technology for Monitoring Neural Activity at the H.C. Wainwright Global Investment Conference on May 25


EDEN PRAIRIE, Minn. , May 19, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ:  NMTC ) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will present at the H.C.


Published on: 2022-05-19 09:30:00

Impact on Symbol / Company: NMTC

View News

NeuroOne Medical Technologies' (NMTC) CEO Dave Rosa on Q2 2022 Results - Earnings Call Transcript


NeuroOne Medical Technologies Corporation (NASDAQ:NMTC ) Q2 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Dave Rosa – Chief Executive Officer Ron Mcclurg – Chief Financial Officer Conference Call Participants Connor Stevenson – Craig-Hallum Ben Haynor – Alliance Global Partners Operator Ladies and gentlemen, thank you for standing by, and welcome to the NeuroOne Medical Technologies Corporation Second Quarter of Fiscal 2022 Earnings Conference Call. Today's call will be conducted by the company's Chief Executive Officer, Dave Rosa; and its Chief Financial Officer, Ron Mcclurg.


Published on: 2022-05-14 11:20:18

Impact on Symbol / Company: NMTC

View News

NeuroOne® to Present its Disruptive Next-Generation Diagnostic Electrode Technology at the NobleCon18 Investor Conference on April 20, 2022


EDEN PRAIRIE, Minn. , April 18, 2022  /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it will present at NobleCon18, Noble Capital Markets' 18th Annual Investor Conference being held April 19-21, 2022.


Published on: 2022-04-18 10:00:00

Impact on Symbol / Company: NMTC

View News

NeuroOne to Present its Game-Changing Neuroscientific Technology at the Oppenheimer 32nd Annual Healthcare Conference and 34th Annual ROTH Conference


EDEN PRAIRIE, Minn., March 3, 2022 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it is scheduled to attend two investor conferences during the month of March 2022.


Published on: 2022-03-03 09:00:00

Impact on Symbol / Company: NMTC

View News

NeuroOne Medical Technologies Corporation (NMTC) CEO Dave Rosa on Q1 2022 Results - Earnings Call Transcript


NeuroOne Medical Technologies Corporation (NMTC) CEO Dave Rosa on Q1 2022 Results - Earnings Call Transcript


Published on: 2022-02-14 18:35:06

Impact on Symbol / Company: NMTC

View News

NeuroOne Medical Technologies' (NMTC) CEO Dave Rosa on Q4 2021 Earnings Call Transcript


NeuroOne Medical Technologies' (NMTC) CEO Dave Rosa on Q4 2021 Earnings Call Transcript


Published on: 2021-12-15 11:32:03

Impact on Symbol / Company: NMTC

View News

NeuroOne to Host Fourth Quarter 2021 Earnings Call


EDEN PRAIRIE, Minn., Dec. 6, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announces today it will host a conference call to discuss financial results for its fourth quarter and fiscal year ended September 30, 2021, on December 15, 2021, at 9:00 AM Eastern Time.


Published on: 2021-12-06 13:55:00

Impact on Symbol / Company: NMTC

View News

NeuroOne: Thin Film Electrodes For Diagnosis And Treatment Of Neurological Conditions


NeuroOne is a developer of flexible, minimally invasive, thin film electrodes for cEEG and sEEG recording, and the diagnosis and treatment of neurological conditions. Mayo Clinic is a key development partner and shareholder, and Zimmer Biomet is a strategic development and marketing partner.


Published on: 2021-11-19 11:54:54

Impact on Symbol / Company: NMTC

View News

NeuroOne Medical Technologies Corporation Announces Pricing of Public Offering of Common Stock


EDEN PRAIRIE, Minn., Oct. 13, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced the pricing of an underwritten registered public offering of 3,750,000 shares of its common stock at a price of $3.20 per share.


Published on: 2021-10-13 08:02:00

Impact on Symbol / Company: NMTC

View News

NeuroOne Medical Technologies Corporation Announces Proposed Public Offering of Common Stock


EDEN PRAIRIE, Minn., Oct. 12, 2021 /PRNewswire/ -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, today announced that it has commenced a proposed underwritten registered public offering of shares of its common stock.


Published on: 2021-10-12 19:03:00

Impact on Symbol / Company: NMTC

View News

Grow your Money

We helps you in understanding the science behind growing the money, which will help you diversify your funds as per your requirements and helps in achieving your retirement goals, children education, investment in property, business or any smart looking startup ventures

Services we Offer

We offer several services including expert recommendations & suggestions on buying ETF, Mutual Funds, Bonds, Debt securities, Equities, Property invesments and several others

Live Market Data

We provide you live market data for your analysis, review and looking out for quick buying opportunities to help you